Bicycle Therapeutics | 4:持股變動聲明-董事 BAKER BROS. ADVISORS LP
Bicycle Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Baker Bros. Advisors LP(19.9%),Baker Bros. Advisors (GP) LLC(19.9%)等
Bicycle Therapeutics | 8-K:重大事件
Bicycle Therapeutics | F-6EF:自動有效登記聲明
Bicycle Therapeutics | 8-K:重大事件
Bicycle Therapeutics | 10-Q:季度報表
Bicycle Therapeutics | 8-K:Bicycle Therapeutics報告了最近的業務進展和2024年第一季度財務業績
Bicycle Therapeutics | 4:持股變動聲明-董事 BAKER BROS. ADVISORS LP
Bicycle Therapeutics | SC 13D:超過5%持股股東披露文件-Baker Bros. Advisors LP(19.9%),Baker Bros. Advisors (GP) LLC(19.9%)等
Bicycle Therapeutics | 3:首次持股聲明-董事 BAKER BROS. ADVISORS LP
Bicycle Therapeutics | DEFA14A:其他
Bicycle Therapeutics | 8-K:重大事件
Bicycle Therapeutics | ARS:年度報告
Bicycle Therapeutics | DEF 14A:股東委託書決議
Bicycle Therapeutics | 4:持股變動聲明-高管 Hannay Michael Charles Ferguson
Bicycle Therapeutics | 144:擬議出售證券
Bicycle Therapeutics | 4:持股變動聲明-高管 Thompson Travis Alvin
Bicycle Therapeutics | 4:持股變動聲明-高管 Crockett Nigel
Bicycle Therapeutics | 4:持股變動聲明-高管 Milnes Alistair
Bicycle Therapeutics | 4:持股變動聲明-高管 Skynner Michael
暫無數據